What is Narayana Hrudayalaya Ltd (NH) share price return in the past 10 years?

Narayana Hrudayalaya Ltd share price has appreciated 20.3% annually (CAGR) over the past ten years.

What is the share price of Narayana Hrudayalaya Ltd (NH)?

Company share prices are keep on changing according to the market conditions. The current trading price of Narayana Hrudayalaya Ltd (NH) on 05-Jun-2026 16:59:59 at 16:59 is 1970.05.

What is the P/E ratio of Narayana Hrudayalaya?

The latest standalone P/E ratio of Narayana Hrudayalaya as of 05-Jun-2026 is 79.16.

What is the P/B ratio of Narayana Hrudayalaya Ltd (NH)?

The latest standalone P/B ratio of Narayana Hrudayalaya Ltd (NH) as of 05-Jun-2026 is 15.33.

What is the 52-week high and low of Narayana Hrudayalaya Ltd (NH)?

The 52-week high of Narayana Hrudayalaya Ltd (NH) is Rs. 2371.60 and the 52-week low is Rs. 1564.25.

Narayana Hrudayalaya Ltd (NH) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Narayana Hrudayalaya Ltd (NH)
Brand: Narayana Hrudayalaya

Key Metrics

Valuation Multiples

Market Cap

₹39,828 Cr.

Current Price

₹1,970.1

52-Week Low / High

₹1,564 / 2,372

TTM EPS

₹39.4

TTM Sales

₹7,896 Cr.

Book Value per Share

₹222

P/E Ratio

49.44

Higher than its 5-year historical median

Industry PE

Price to Book (P/B)

8.78

In line with its 5-year historical median

Price to Sales (P/S)

5.04

In line with its 5-year historical median

EV/EBITDA

24.79

Higher than its 5-year historical median

Dividend Yield

0.27%

Profitability Efficiency

Return on Equity (ROE)

24.27%

Outperforms industry median

Return on Capital Employed (ROCE)

21.62%

Outperforms industry median

Return on Assets (ROA)

12.07%

Operating Profit Margin

23.7%

Net Profit Margin

14.4%

Gross Profit Margin

22.3%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

12.12%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

12.92%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

0.49%

Asset Quality

Promoter Holding

63.27%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹4,333 Cr.

Equity

₹204.4 Cr.

Face Value

₹10

All Time Low / High

₹181.35 / 2371.60

Narayana Hrudayalaya stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Somewhat Overvalued

Check Valuation charts

Price Trend

Strong

Check Price chart

Q.1 Is Narayana Hrudayalaya Ltd a good quality company?

Narayana Hrudayalaya Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Narayana Hrudayalaya Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Narayana Hrudayalaya Ltd vs industry peers?

Narayana Hrudayalaya Ltd revenue CAGR is 11.88%, compared to the industry median CAGR of 15.55%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Narayana Hrudayalaya Ltd?

Promoters hold 63.27% of the Narayana Hrudayalaya Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Narayana Hrudayalaya Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 19.4% based on the current price.

DeciZen - make an informed investing decision on Narayana Hrudayalay

Consolidated basis

1. Right Stock

10 Year X-ray Pro

Long Term Prospect

2. Right Price

Price Chart

3. Right Time ⓘ

#Likely Future 5 Year CAGR.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	7.5%	14.1%	8.9%	9.3%	13.6%	1.5%	26.8%	33.9%	27.6%	21.6%	-
Value Creation Index ⓘ	-0.5	0.0	-0.3	-0.3	0.0	-0.9	1.0	1.5	1.5	0.9	-
Growth Parameters ⓘ
Sales ⓘ	1,614	1,878	2,281	2,861	3,128	2,583	3,701	4,525	4,890	5,483	7,896
Sales YoY Gr.	-	16.4%	21.4%	25.4%	9.3%	-17.4%	43.3%	22.3%	8.1%	12.1%	-
Adj EPS ⓘ	1.5	4.2	2.6	2.8	5.8	-0.5	17	29.7	38.3	38.5	39.4
YoY Gr.	-	182.3%	-37.6%	8.9%	106.7%	-108.2%	NA	74.5%	29.3%	0.4%	-
BVPS (₹) ⓘ	42.7	46.7	50	52.8	55.4	54.6	72.7	104.3	141.1	177.4	222
Adj Net Profit ⓘ	30	84.8	52.9	57.7	119	-9.9	347	606	784	786	806
Cash Flow from Ops. ⓘ	174	219	182	279	443	304	485	1,085	1,067	986	-
Debt/CF from Ops. ⓘ	1.5	1	4.4	2.9	1.6	2	1.1	0.7	1.4	2.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14.6%	11.9%	14%	12.1%
Adj EPS ⓘ	43.7%	45.9%	31.3%	0.4%
BVPSⓘ	17.2%	26.2%	34.7%	25.8%
Share Price	20.3%	31.9%	29.9%	12.4%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	3.6	9.2	5.3	5.5	10.7	-0.9	26.6	33.5	31.3	24.2	19.7
Op. Profit Mgn % ⓘ	11.1	12.3	9.8	10.3	13.9	7.6	18.2	21.8	23.5	23.7	20.5
Net Profit Mgn % ⓘ	1.8	4.5	2.3	2	3.8	-0.4	9.4	13.4	16	14.4	10.2
Debt to Equity ⓘ	0.3	0.2	0.8	0.8	0.6	0.6	0.4	0.4	0.5	0.6	1
Working Cap Days ⓘ	81	72	79	78	70	79	65	69	83	84	72
Cash Conv. Cycle ⓘ	4	-4	-3	-3	-9	-14	-13	-17	-23	-14	39

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	1,614	1,878	2,281	2,861	3,128	2,583	3,701	4,525	4,890	5,483
Operating Expenses ⓘ +	1,437	1,649	2,061	2,566	2,701	2,394	3,038	3,544	3,745	4,190
Manufacturing Costs	534	625	776	929	988	862	1,080	1,287	1,348	1,478
Material Costs	387	436	557	688	745	678	909	1,001	1,030	1,136
Employee Cost	334	375	466	623	674	627	768	879	982	1,093
Other Costs ⓘ	182	213	263	327	294	227	280	377	384	482
Operating Profit ⓘ	177	229	220	295	427	189	663	980	1,145	1,293
Operating Profit Margin (%)	11.0%	12.2%	9.6%	10.3%	13.6%	7.3%	17.9%	21.7%	23.4%	23.6%
Other Income ⓘ +	16	23	19	19	28	27	35	65	92	92
Exceptional Items ⓘ	-11	-1	1	0	-11	0	0	0	0	-8
Interest ⓘ	33	28	55	81	94	82	76	84	112	163
Depreciation ⓘ	76	80	100	137	186	184	183	210	241	278
Profit Before Tax ⓘ	51	135	80	93	161	-56	430	752	884	936
Tax ⓘ	30	52	29	34	42	-42	88	145	98	146
Profit After Tax	21	83	51	59	119	-14	342	607	786	790
PAT Margin (%)	1.3%	4.4%	2.3%	2.1%	3.8%	-0.6%	9.2%	13.4%	16.1%	14.4%
Adjusted EPS (₹)	1.0	4.1	2.5	2.9	5.8	-0.7	16.7	29.7	38.6	38.7
Dividend Payout Ratio (%)	0%	0%	0%	34.50%	17.20%	0%	6%	8.40%	10.40%	11.60%

Valuation of Narayana Hrudayalay - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	873	954	1,022	1,079	1,133	1,117	1,485	2,131	2,884	3,626
Share Capital ⓘ	204	204	204	204	204	204	204	204	204	204
Reserves ⓘ	668	749	818	874	928	912	1,281	1,926	2,679	3,422
Debt +	232	189	734	737	629	525	444	639	1,220	1,977
Long Term Debt	188	180	696	725	619	504	432	626	1,195	1,966
Short Term Debt	45	9	38	12	11	21	11	13	25	10
Minority Interest	0	0	0	0	1	1	1	1	1	2
Trade Payables	161	207	305	334	362	410	449	615	604	574
Others Liabilities ⓘ	290	297	466	484	765	715	754	772	1,024	1,180
Total Liabilities ⓘ	1,556	1,647	2,528	2,633	2,889	2,768	3,133	4,157	5,732	7,359
Fixed Assets
Net Fixed Assets ⓘ +	1,055	1,082	1,848	1,838	2,092	1,961	1,980	2,336	2,651	4,266
Gross Block	1,417	1,522	2,385	2,504	2,943	2,982	3,155	3,671	4,137	5,930
Accumulated Depreciation	363	440	537	666	851	1,022	1,175	1,334	1,486	1,664
CWIP ⓘ	14	53	35	56	12	20	67	259	514	86
Investments ⓘ	87	96	9	17	86	120	132	252	844	1,084
Inventories	50	52	84	83	60	48	59	72	110	110
Trade Receivables	152	157	279	266	262	279	437	432	422	555
Cash Equivalents	24	34	35	101	115	132	172	380	416	647
Others Assets ⓘ	175	173	238	271	262	209	285	427	775	610
Total Assets ⓘ	1,556	1,647	2,528	2,633	2,889	2,768	3,133	4,157	5,732	7,359

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	174	219	182	279	443	304	485	1,085	1,067	986
PBT ⓘ	51	135	80	93	161	-56	430	752	889	937
Adjustment ⓘ	136	112	162	231	295	250	274	313	285	391
Changes in Working Capital ⓘ	22	8	-27	8	53	56	-152	105	-15	-215
Tax Paid ⓘ	-35	-37	-34	-54	-66	54	-67	-86	-91	-127
Cash Flow From Investing Activity ⓘ +	-150	-146	-534	-161	-189	-113	-267	-1,174	-1,458	-1,325
Capex	-90	-119	-203	-150	-114	-70	-250	-521	-968	-1,079
Net Investments	-3	-19	-174	-12	-75	-51	-18	-417	-509	-263
Others ⓘ	-57	-9	-157	1	1	8	1	-236	18	16
Cash Flow From Financing Activity ⓘ +	18	-45	315	-27	-247	-194	-159	88	488	544
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	49	-5	347	28	-108	-102	-68	208	368	294
Interest Paid ⓘ	-25	-21	-32	-55	-51	-43	-36	-43	-73	-116
Dividend Paid ⓘ	0	0	0	0	-49	0	0	-20	-51	-81
Others ⓘ	-6	-20	0	0	-39	-48	-55	-57	244	447
Net Cash Flow ⓘ	42	28	-36	90	8	-2	59	-2	97	205

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	2.54	9.09	5.2	5.64	10.77	-1.27	26.3	33.55	31.35	24.27
ROCE (%)	7.45	14.09	8.94	9.34	13.61	1.46	26.83	33.92	27.58	21.62
Asset Turnover Ratio	1.1	1.17	1.09	1.11	1.13	0.91	1.25	1.24	0.99	0.84
PAT to CFO Conversion(x)	8.29	2.64	3.57	4.73	3.72	N/A	1.42	1.79	1.36	1.25
Working Capital Days
Receivable Days	33.30	30	34.90	34.80	30.90	38.20	35.30	35	31.90	32.50
Inventory Days	11.40	9.90	10.90	10.60	8.40	7.60	5.30	5.30	6.80	7.30
Payable Days	140	153.90	167.80	169.50	170.20	207.80	172.50	194	215.90	189.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Narayana Hrudayalaya Ltd FAQs

The current trading price of Narayana Hrudayalay on 05-Jun-2026 16:59 is ₹1,970.1.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Narayana Hrudayalay stood at ₹39,827.9 Cr

The latest P/E ratio of Narayana Hrudayalay as of 04-Jun-2026 is 79.16.

The latest P/B ratio of Narayana Hrudayalay as of 04-Jun-2026 is 15.33.

The 52-week high of Narayana Hrudayalay is ₹2,371.6 and the 52-week low is ₹1,564.3.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Narayana Hrudayalay is ₹3,975 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Narayana Hrudayalaya Ltd is a good quality company.

The key valuation ratios of Narayana Hrudayalaya Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Narayana Hrudayalaya Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Limited was incorporated on July 19, 2000 under the Companies Act, 1956. The Company, headquartered in Bengaluru is engaged in providing economical healthcare services. The Company was rebranded as ‘Narayana Health’ in 2013. It has a network of multispecialty and superspeciality hospitals spread across multiple locations.

The company was founded by its Promoter Devi Prasad Shetty, who has over 30 years of medical experience, including as a cardiac surgeon. The company is headquartered in Bengaluru, India, and operates a national network of hospitals in India with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in western and central India. The company’s ‘Narayana Health’ brand is strongly associated with its mission to deliver high quality and affordable healthcare services to the broader population by leveraging its economies of scale, skilled doctors, and an efficient business model.

Business area of the company

The company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals.

Products and Services

Anaesthesia & Critical Care
Blood Bank
Bone Marrow Transplant
Breast Cancer
Cardiac Surgery - Adult
Cardiology - Adult
Clinical Nutrition & Dietetics
Cranio-Maxillo Facial Surgery
Dental Sciences
Dermatology and Cosmetology
Developmental Medicine
Diabetology
E.N.T
Electrophysiology
Emergency Medicine
Endocrinology
Family Medicine
Gastroenterology - Medical
Gastroenterology - Surgical
Gastrointestinal Oncology
General Surgery
Genetics
Geriatrics
Gynaecology - Oncology
Haemato Oncology
Haematology
Head & Neck Surgery - Oncology
Heart Transplant
Infectious Diseases
Integrative Oncology
Internal Medicine
Interventional Radiology
Kidney Transplant - Adult
Lab
Liver Transplant & HPB Surgery
Medical Oncology
Microbiology
Nephrology
Neurology
Neurosurgery
NICU & PICU
Nuclear Medicine
Obstetrics & Gynaecology
Oncology
Ophthalmology
Ortho - Oncology
Orthopaedics
Pain & Palliation - Oncology
Pathology
Physical Medicine and Rehabilitation
Physiotherapy & Rehabilitation
Plastic Surgery
Psychiatry & Clinical Psychology
Pulmonology
Radiation Oncology
Radiology
Reproductive Medicine
Rheumatology
Robotic Surgery
Speech And Swallow Rehabilitation
Spine Surgery
Surgical Oncology
Thoracic Surgery
Uro - Oncology
Urology
Vascular Surgery

Awards

2010:

Awarded as the Best Single Speciality Hospital - Cardiology at 'India Healthcare Awards 2010'

2011:

A proud recipient of the “India Shining Star CSR Award' for the exceptional CSR work in the health sector

2012:

FICCI Health Care Excellence Award
Frost and Sullivan India Healthcare Excellence Awards

2013:

Financial Times Arcelor Mittal Boldness in Business Awards
Inc. India Innovative 100 Award

2014:

Narayana health was recognised among world’s top 50 ‘BCG Local Dynamos 2014’ for its exceptional operational efforts.
Gold Award winner in Customer Service by Asian Hospital Management Awards
Winner of ABP News Brand Excellence Award 2014

2015:

Identified for its exceptional work in the department of cardiology, NICS has been named the Best Single Specialty Hospital in India, Cardiology in the CNBC TV 18 & ICICI Lombard India Healthcare Award 2015-16
Recognized for its technology enabled innovative primary healthcare services to people living in resource deprived locations in India, Narayana Health has been awarded Public Health Champion Award by WHO India under the category of Innovation
NH receives the Healthcare Leadership Awards by Stars of the Industry Group in 2 categories; Outstanding Achievement Awards Healthcare - Social Cause, Healthcare & Social Care Support Award

2016:

Health Brand of the Year - Healthcare - India Health & Wellness Awards
Quality beyond Accreditation for NH Jaipur at the Global Conclave of Association of Health Care Providers India (AHPI)

2017:

Narayana Health was recognized as one of the Best Asian Healthcare Brands by the Economic Times, for its immense contributions & unique initiatives to improve the healthcare industry.
Best Cardiac Science Institute of the Year
Narayana Superspeciality Hospital Howrah was recognized as the Best Superspeciality Hospital of the Year (Oncology) at the International Healthcare Awards 2017 - country's most authoritative Summit & Awards for the healthcare industry.

2018:

Narayana Health won the Silver in Reproductive and Sexual Health Category at India Health & Wellness Summit and Awards.
Narayana Health listed in Fortune India 500
CSR Excellence in Healthcare

Milestones

2000: Commenced operations from NICS in Bengaluru
2008: The company entered into an investment agreement with the investor Selling Shareholders for the purpose of subscription by the investor Selling Shareholders to 75,414 Equity Shares of Rs 10 each of the company (in the aggregate) for a purchase price of Rs 53,040.55 (approximately) per share, including share premium of Rs 53,030.55 (approximately) per share.
2014: Acquired AHDL.
2014: Acquired the Jubilant Kalpataru Hospital, Barasat, West Bengal.
2014: The company entered into a securities subscription agreement with CDC Group and CDC IOL for subscription to its equity shares and OCDs aggregating to around Rs 300 crore.
2015: Obtained JCI accreditation for HCCI's multispecialty hospital in Cayman Islands.
2018: Narayana Health City Launches ‘Senior Citizen’s Privilege Card’
2018: Narayana Superspeciality Hospital empaneled with CGHS & NHPC
2019: Narayana Health Guwahati opens Day care dialysis center.
2019: Narayana Multispeciality Hospital Launches A Comprehensive Weight Loss Clinic : 1st In Mysore
2019-20: SRCC Children’s Hospital, Mumbai completed 1,000 paediatric cardiac surgeries since its inception strengthening facility’s position as a top-notch medical destination for paediatric treatment
2019-20: Foundation stone laid for setting up a comprehensive Radiation Centre at Health City Cayman Islands
2019-20: Company signed a 3-year contract to deploy and manage NH’s Proprietary Data Intelligence Platform - MEDHA for a PanIndia Hospital Group

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Narayana Hrudayalaya Ltd (NH)

Narayana Hrudayalaya Ltd (NH)

Narayana Hrudayalaya stock performance

Check Before You Invest

Quality

Valuation

Price Trend

DeciZen - make an informed investing decision on Narayana Hrudayalay

1. Right Stock

2. Right Price

3. Right Time ⓘ

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Narayana Hrudayalay - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Narayana Hrudayalaya Ltd FAQs

What is the share price of Narayana Hrudayalay?

What is the market cap of Narayana Hrudayalay?

What is the P/E ratio of Narayana Hrudayalay?

What is the P/B ratio of Narayana Hrudayalay?

What is the 52-week high and low of Narayana Hrudayalay?

What is the TTM revenue of Narayana Hrudayalay?

Is Narayana Hrudayalaya Ltd a good quality company?

Is Narayana Hrudayalaya Ltd undervalued or overvalued?

Is Narayana Hrudayalaya Ltd a good buy now?

About Narayana Hrudayalaya Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.